Directory of Clinical Research Companies

in Delhi& NCR :

Company : Apothecaries Ltd.

Company Description :
Apothecaries Foundation - a non profit organization independent
of any pharmaceutical organization - has been formed with the
objective of providing leadership and direction towards
inculcating Good Clinical Practices (GCP) in Bio-Medical
Research in India.
The Foundation plans to achieve this by organizing short term
courses, interaction meetings, symposia, seminars and regular
out-reach programs over the internet.
Contact details:
579 Devli East Sainik Farms,
New Delhi 110 062
E-Mail: cro@apothecaries.net
URL: www.apothecaries.net

Company : Eli Lilly and Company (India) Pvt. Ltd

Company Description :
It is a subsidiary of the US pharmaceutical major, Eli Lilly and
Company. The company was set up in 1993 as a 50:50 joint
venture between Eli Lilly and the Indian partner Ranbaxy
Laboratories Ltd., as Eli Lilly Ranbaxy Ltd.
The global pharmaceutical giant has 17 large and small clinical
research projects running in 40 hospitals across India. The
company's clinical trials are to test if Xigris, can be used for
sepsis. Eli Lilly has already held clinical trials involving more than
600 patients for Human Insulin and Insulin Lispro. It is also these
days conducting trials on oncology, and developing a new
molecule for lung cancer. Other areas are Diabetes, Cardiology ,
Oncology, Bacterial Infections, Severe Sepsis, Severe
Osteoporosis, Growth Hormone therapeutic sectors
Director /
CEO
Sidney Taurel: Chairman, President and Chief Executive Officer
Contact
details
Plot # 92, Sector 32,
Institutional Area,
Gurgaon-122001Haryana, INDIA
Tel : +91-124-2823000,01
Fax : +91-124-2823012, 13
Email : lillyindia@lilly.com

Company : Jubilant Clinsys

Company Description :
The Company conducts bioavailability, bioequivalence,
Pharmacokinetic and phase 1 studies as per ICH-GCP and
USFDA guidelines. The Company has set up a 40-bed facility
spread over nearly 35000 sq. ft. area in Noida functional by end
of 2004. This facility is DCGI-India, USFDA, UK-MHRA and
ANVISA-Brazil certified and the Company would go for these
accreditations in due course of time. The facility will be equipped
to perform all the services required to conduct a
bioavailability/bioequivalence study like screening (path lab,
biochemistry etc), clinical phase on healthy adult human subjects,
for bioavailability and bioequivalence studies. These facilities
under one roof will avoid the transport of volunteers and samples
from one facility to the other facility.
Director /
CEO
Dr. Surinder Kher
Contact
details
C-46, sector -62,
Noida - 201 301
Tel: +91-124- 2404333
Fax : +91-120 2516627
E-mail : abhinav_rahul@jubl.com
abhinandan@cdr-india.com
URL: www.jubilantorganosys.com

Company Kendle India

Company
Description
Kendle is among the world s leading global clinical research
organizations, delivering innovative and robust clinical
development solutions to biopharmaceutical companies.
It established an office with full capabilities in India. The staffs
here are experienced in patient recruitment and have wide
therapeutic experience, with key areas including oncology,
psychiatry, cardiovascular, neurology, and infections.
Director /
CEO
Bharat B. Doshi, M. Pharmacy, Country Manager
Contact
details
23-24, Vatika Business Center,
2nd floor, First India Place,
Block B, Mehrauli-Gurgaon Road,
Sushant Lok-1 Gurgaon, UP 122 002
Tel: +91-124-506 7071 / +91 124 502 8935
Fax: +91-124-502 8934 / +91 124 502 8800
Email: doshi.bharat@kendle.com
URL: www.kendle.com

Company Ranbaxy Laboratories

Limited
Company
Description
Ranbaxy Laboratories Limited, headquartered in India, is an
integrated, research based, international pharmaceutical
company producing a wide range of quality, affordable generic
medicines, trusted by healthcare professionals and patients
across geographies. It is ranked amongst the top ten generic
companies worldwide.
The Company s products are sold in over 100 countries with
manufacturing operations in 7 countries and ground presence in
46. The Company has established state-of-the-art multidisciplinary
R&D facilities at Gurgaon (near New Delhi), India.
Experience areas include
Chemical Research (Synthetic Chemistry, APIs)
Pharmaceutical Research (Dosage forms)
Novel Drug Delivery System (NDDS)
New Drug Discovery Research (NDDR)
Fermentation Research (APIs)
Director /
CEO
Brian W. Tempest CEO & Managing Director
Contact
details
Plot 90, Sector 32,
Gurgaon -122001 (Haryana), INDIA
Tel: 91- 124- 5135000
Email:seema.ahuja@ranbaxy.com
URL: http://www.ranbaxy.com